Nora520
Postpartum Depression
DuKang Pharmaceuticals, Inc.Phase 2Active
B
57/ 100
Provisional rating · Methodology v0.2
Rating breakdown
- Clinical Evidence
- 42/ 100
- Competitive Position
- 95/ 100
Competitive context
3 Active assets in the Postpartum Depression cohort.
| Asset / Sponsor | Phase | Rating |
|---|---|---|
ALLOPREGNAN-3.ALPHA.-OL-20-ONE Supernus Pharmaceuticals, Inc. | Phase 3 | BBB |
Sertraline London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's | Phase 4 | BB |
Zuranolone Biogen | Phase 3 | BB |
CYCLOHEXANEACETIC ACID, 1-(AMINOMETHYL)- Stanford University | Phase 4 | BB |
Lpcn 1154A Lipocine Inc. | Phase 3 | BB |
View all 12 →
Are you the sponsor?
Submit your data room for a Verified Rating. The public-data rating remains visible alongside.
Contact →